Overview
Tongkat Ali (Eurycoma longifolia) is a Southeast Asian medicinal root extract that has become one of the most researched natural testosterone-supporting supplements. Traditionally used as an adaptogen and male health tonic, it is now widely studied for its ability to enhance hormonal balance, support sexual function, improve physical performance, and reduce stress markers. The supplement is primarily used by men seeking to optimize testosterone levels, improve libido, enhance fertility, reduce cortisol elevation, and boost athletic performance.
The plant's biological activity stems from a complex mixture of compounds: quassinoids (particularly eurycomanone), alkaloids, and peptides. These work synergistically through multiple mechanisms to support male hormonal health and physical performance.
How It Works: Mechanism of Action
Tongkat Ali operates through several interconnected biological pathways:
Primary Hormonal Mechanisms
The supplement's main testosterone-enhancing effect occurs through inhibition of sex hormone-binding globulin (SHBG). SHBG binds to testosterone and reduces its bioavailability; by decreasing SHBG levels, Tongkat Ali increases the proportion of free testosterone available for biological activity.
Additionally, Tongkat Ali stimulates Leydig cell steroidogenesis, enhancing the body's own endogenous testosterone production. This addresses the root cause of low testosterone rather than simply adding exogenous hormone.
Aromatase Inhibition and Estrogen Balance
Eurycomanone, the principal active quassinoid in Tongkat Ali, inhibits the enzyme aromatase (CYP19A1), which normally converts testosterone to estrogen. This dual action—increasing testosterone production while reducing its conversion to estrogen—helps maintain a favorable testosterone-to-estrogen ratio, particularly important as men age.
Erectile Function and Sexual Signaling
Beyond hormonal effects, eurycomanone acts as a phosphodiesterase inhibitor, supporting cyclic AMP (cAMP) signaling pathways critical to erectile function and libido. This mechanism parallels the action of prescription phosphodiesterase inhibitors, though the effect is more modest.
Stress Hormone Modulation
Tongkat Ali modulates the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system. By reducing cortisol levels and improving the testosterone-to-cortisol ratio, it exerts adaptogenic effects that may enhance resilience to physical and psychological stress.
Evidence by Health Goal
Hormonal Balance (Tier 4 — Strong Evidence)
Tongkat Ali demonstrates the strongest evidence for increasing testosterone levels in men, particularly those with late-onset hypogonadism or age-related androgen deficiency.
A meta-analysis of 5 randomized controlled trials found that Tongkat Ali significantly increased total testosterone in both healthy men and hypogonadal men (standardized mean difference = 1.352, 95% CI 0.565–2.138, p = 0.001).
In one key study involving 105 men aged 50–70 years with baseline testosterone below 300 ng/dL, supplementation with 200 mg daily of Physta® (a standardized extract) increased total testosterone at weeks 4 (p < 0.05), 8 (p < 0.01), and 12 (p < 0.001) compared to placebo.
Effects in healthy young men and menopausal women are more modest and less consistently demonstrated across studies.
Sexual Health & Erectile Function (Tier 3 — Probable Evidence)
Multiple RCTs support modest improvements in erectile function and testosterone, the primary driver of sexual health in men.
A meta-analysis of 5 RCTs documented significant testosterone increase (SMD = 1.352, 95% CI 0.565-2.138, p = 0.001) in men receiving Eurycoma longifolia supplementation.
In healthy young males (n=32), 600 mg daily for 2 weeks significantly increased both total testosterone (F = 9.04, p = 0.005) and free testosterone (F = 7.13, p = 0.012).
However, effect sizes on erectile function scores themselves remain modest, and most studies have small sample sizes.
Athletic Performance (Tier 3 — Probable Evidence)
Tongkat Ali shows promising effects for strength and power when combined with resistance training, though evidence is limited to short intervention periods.
In one study of 45 men with androgen deficiency, those combining concurrent resistance and power training with Tongkat Ali supplementation achieved a 17% increase in isokinetic peak torque of knee extensors over 6 months, compared to 14% in the training-only group.
Importantly, testosterone levels correlated with isokinetic strength (r = 0.517 for extension, r = 0.362 for flexion), suggesting that the supplement's performance benefits are mediated through hormonal improvements. Evidence for isolated supplementation without concurrent exercise remains limited.
Muscle Growth (Tier 2 — Plausible Evidence)
While Tongkat Ali consistently increases testosterone—a primary driver of muscle growth—direct evidence for lean mass or strength gains in humans is absent. Studies have measured testosterone levels but not muscle outcomes like lean mass, cross-sectional area, or strength gains independent of exercise.
This distinction is important: testosterone elevation is a necessary but not sufficient condition for muscle growth. Combined with resistance training, elevated testosterone can support hypertrophy; in isolation, the effect may be negligible.
Fat Loss (Tier 3 — Probable Evidence)
CitruSlim, a supplement containing Eurycoma longifolia, significantly reduced body mass index compared to placebo in obese individuals over 112 days (n = 97, double-blind RCT), though the specific effect size was not reported in available abstracts.
Animal studies provide supporting mechanistic evidence: E. longifolia extract suppressed body weight gain, decreased epididymal and perirenal fat pad mass, and reduced hepatic steatosis in high-fat diet mice over 12 weeks.
However, human evidence consists of a single moderate-quality trial with a blended product, and long-term efficacy remains unproven.
Mood & Stress Resilience (Tier 3 — Probable Evidence)
Multiple small-to-moderate RCTs demonstrate improvements in mood scores and quality of life, though effect sizes are often modest.
In 93 moderately stressed healthy adults over 24 weeks, Tongkat Ali combined with multivitamins improved the mental component of the SF-12 quality-of-life scale (P < 0.001), emotional well-being (P < 0.001), and vitality (P = 0.001), with within-group improvements on the Profile of Mood States (POMS). However, between-group differences versus placebo were not consistently significant.
In 63 moderately stressed subjects (32 men, 31 women), salivary cortisol was reduced by 16% and total testosterone increased by 37% after 4 weeks of supplementation (P < 0.05).
Results are less consistent than the hormonal evidence and often rely on subjective mood scales.
Energy & Fatigue (Tier 3 — Probable Evidence)
Four RCTs support improvements in energy and fatigue, though evidence relies heavily on subjective quality-of-life and mood scales rather than objective measures of physical energy.
The cortisol reduction (16%) and testosterone increase (37%) documented in the moderately stressed population likely underlie energy improvements. Most studies last 4–24 weeks with sample sizes between 63–150 participants.
Immune Support (Tier 3 — Probable Evidence)
Two RCTs demonstrate improved immune markers, but evidence remains limited by small sample sizes and lack of independent replication.
In 83 middle-aged adults receiving 200 mg daily for 4 weeks, Tongkat Ali significantly increased Scoring of Immunological Vigor (SIV) and immunological grade compared to placebo (p < 0.05).
The same study found significantly higher CD4+ T cell counts, total T cells, and naive T cells in the Tongkat Ali group versus placebo after 4 weeks (p < 0.05).
Longevity & Aging (Tier 3 — Probable Evidence)
Tongkat Ali shows consistent improvements in multiple biomarkers relevant to healthy aging: testosterone, muscle strength, mood, and stress markers across multiple RCTs. However, evidence is limited by small sample sizes (most n < 150), short intervention periods (4–12 weeks), and the absence of direct longevity endpoints such as lifespan or mortality reduction.
Sleep Quality (Tier 2 — Plausible Evidence)
Animal studies suggest sleep-enhancing effects through circadian rhythm modulation and melatonin biosynthesis pathways. In mice, Tongkat Ali supplementation consolidated non-REM (NREM) sleep with longer bout duration and increased REM sleep during resting periods. The supplement also enhanced slow-wave activity at delta frequencies (0.5–4.0 Hz).
However, human efficacy for sleep remains unproven. Two human RCTs measured sleep quality as a secondary outcome, but results were unclear or unreported, and no well-designed human sleep studies exist.
Bone Health & Injury Recovery (Tier 2 — Plausible Evidence)
Tongkat Ali shows promise for bone health in animal models. Quassinoid-rich Eurycoma longifolia extract prevented bone loss in castrated male rats at doses of 25–100 mg/kg, with effects on bone biochemical markers, serum testosterone, and RANKL/OPG ratios.
Eurycomanone enhanced skull mineralization and increased mRNA expression of osteoblast formation genes (ALP, Runx2, Osterix) in zebrafish larvae.
However, no human clinical evidence demonstrates efficacy for injury recovery or fracture healing.
Anti-Inflammation (Tier 2 — Plausible Evidence)
Tongkat Ali shows consistent anti-inflammatory effects in cell and animal studies through NF-κB and nitric oxide inhibition.
In macrophage cell cultures, isolated alkaloids and phenolic compounds from Tongkat Ali roots inhibited lipopolysaccharide-induced nitric oxide production dose-dependently at 10–50 µM concentrations. Three quassinoids (eurycomalactone, 14,15β-dihydroklaieanone, and 13,21-dehydroeurycomanone) demonstrated potent NF-κB inhibition with IC50 values below 1 µM.
Clinical efficacy in inflammation is limited to one small human RCT examining menopausal symptoms with modest results.
Heart Health (Tier 2 — Plausible Evidence)
Evidence is mixed. CitruSlim (containing Tongkat Ali) did not improve dyslipidemia or metabolic disturbances in obese individuals (n = 97, double-blind RCT, 112 days).
In-vitro studies show potential: a dichloromethane fraction of Eurycoma longifolia inhibited ACE (angiotensin-converting enzyme) activity and attenuated angiotensin II-induced aortic contraction in rat aortic rings.
However, human efficacy for heart health is not proven. One case report documented atrial flutter attributed to the supplement, warranting caution in those with cardiac arrhythmia history.
Liver Health (Tier 1 — No Clear Evidence)
Standard liver function tests remained normal in 105 aging men supplemented with 100–200 mg Physta daily for 12 weeks. Similarly, in a separate study, 26 men given 300 mg Physta combined with Polygonum minus for 12 weeks showed no clinically significant liver function abnormalities.
However, one case report documents acute liver injury attributed to the supplement, suggesting that contaminated or adulterated products may pose hepatic risk. Individuals with pre-existing liver conditions should avoid supplementation.
Cognition (Tier 1 — No Evidence)
No evidence demonstrates that Tongkat Ali improves cognition in humans. In a 36-month observational study (n = 1,285 with complete data), cognitive function improved in both Tongkat Ali users and non-users with no significant difference between groups, indicating no cognitive benefit attributable to supplementation.
Gut Health (Tier 2 — Plausible Evidence)
Tongkat Ali shows anti-parasitic and anti-protozoal activity in laboratory studies against gastrointestinal pathogens, but no human clinical trials demonstrate efficacy for gut health.
Tongkat Ali extract and eurycomanone induced high apoptotic rates in Blastocystis sp. in vitro and reduced viable cell counts compared to metronidazole. Eurycoma longifolia crude extract also inhibited motility of intestinal fluke juveniles.
However, evidence is limited to in-vitro and animal models. Human efficacy remains unproven.